Compare WRAP & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WRAP | STXS |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.5M | 86.4M |
| IPO Year | 2017 | 2004 |
| Metric | WRAP | STXS |
|---|---|---|
| Price | $1.13 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.67 |
| AVG Volume (30 Days) | 507.4K | ★ 905.0K |
| Earning Date | 11-16-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ N/A |
| Revenue | $4,672,000.00 | ★ $29,346,617.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $27.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $0.98 | $0.80 |
| 52 Week High | $6.00 | $2.86 |
| Indicator | WRAP | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 38.37 | 36.02 |
| Support Level | N/A | $0.80 |
| Resistance Level | $1.71 | $1.97 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 8.50 | 4.71 |
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.